Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 28, 2021Open Access

Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants

View Full Paper
Ask AI
Bookmark
Share

Authors

ACAngela ChoiModerna Therapeutics (United States)MKMatthew KochNorthwestern University
Kaichun Wu
Kaichun WuAir Force Medical University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Choi et al. (2021) studied this question.

synapsesocial.com/papers/6a9ce2620f77d4edee5603fchttps://doi.org/10.1101/2021.06.28.449914
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine2020 · 10,918 citations
  2. 2Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine2021 · 471 citations
  3. 3An mRNA Vaccine against SARS-CoV-2 — Preliminary Report2020 · 3,519 citations
  4. 4Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults2020 · 1,640 citations